Evidence map›Paper›PMID 35985194›Full record

ArticleTalanta2023

Multiple ligation-Assisted recombinase polymerase amplification for highly sensitive and selective colorimetric detection of SARS-CoV-2.

Tasnima Alam Asa, Pradeep Kumar, Jaehyeon Lee, Young Jun Seo

Open access · greenAbstract read
In one paragraph

Article in Talanta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tasnima Alam AsaDepartment of Chemistry, Jeonbuk National University, Jeonju, 54896, South Korea.
Pradeep KumarDepartment of Chemistry, Jeonbuk National University, Jeonju, 54896, South Korea.
Jaehyeon LeeDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, 54896, South Korea.
Young Jun SeoDepartment of Chemistry, Jeonbuk National University, Jeonju, 54896, South Korea. Electronic address: yseo@jbnu.ac.kr.
Jeonbuk National University · KRJeonju National University of Education · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper we present a new method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), targeting a specific region "N gene." Under isothermal reaction conditions, we integrated ligation (Lig; high selectivity) and recombinase polymerase amplification (RPA; high sensitivity) processes, obtaining a robust method of detection. For point-of-care testing, we incorporated our laboratory-produced pyrophosphate ion (PPi)-sensing probe (PK-probe) for colorimetric analysis of the reaction. The total detection system was efficient and effective at diagnosing this RNA virus-mediated disease rapidly (30 min). In a full-genome SARS-CoV-2 study, our PK-probe/Lig-RPA system functioned with a limit of detection of 1160 copies/ml, with a single-mismatch level of selectively, and it was highly selective even in the presence of bacterial genomes commonly found in the human mouth and nose. This robust, straightforward, selective, efficient, and ultrasensitive colorimetric detection method, with potential for point-of-care analysis, should also be effective in detecting a diverse range of other RNA-based diseases.

Indexed as

COVID-19SARS-CoV-2ColorimetryHumansNucleic Acid Amplification TechniquesRecombinasesRNA, ViralSensitivity and SpecificityRecombinasesRNA, ViralColorimetric sensingIsothermal amplificationPK-probePyrophosphateRecombinase polymerase amplification (RPA)SARS-CoV-2

Identifiers

PMID35985194
PMCPMC9375730
OpenAlexW4291298187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.